The US pharmaceutical company Novavax has applied for market approval in the European Union for its corona vaccine.
The Amsterdam-based EU Medicines Agency (EMA) announced on Wednesday that it had already started testing and that it is expected to announce a decision in "a few weeks".
The vaccine is a so-called dead vaccine, which contains killed components of the novel coronavirus for immunization.
More soon on FAZ.NET